NALDINI, Luigi

NALDINI, Luigi  

Dip. SCIENZE ONCOLOGICHE - Candiolo (attivo dal 01/01/2002 al 30/04/2013)  

Mostra records
Risultati 1 - 14 di 14 (tempo di esecuzione: 0.063 secondi).
Titolo Data di pubblicazione Autore(i) File
Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. 1995 NALDINI L ;VIGNA E ;BARDELLI A ;FOLLENZI A ;GALIMI F ;COMOGLIO PM
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. 1992 NALDINI L ;TAMAGNONE L ;VIGNA E ;SACHS M ;HARTMANN G ;BIRCHMEIER W ;DAIKUHARA Y ;TSUBOUCHI H ;BLASI F ;COMOGLIO PM
Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence 2003 Cavalieri, Simona; Cazzaniga, Sabrina; Geuna, Massimo; Magnani, Zulma; Bordignon, Claudio; Naldini, Luigi; Bonini, Chiara
Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient 2002 PIACIBELLO W; BRUNO S; SANAVIO F; GUNETTI M; AILLES L; SANTONI DE SIO F; VIALE A; GAMMAITONI L; LOMBARDO A; NALDINI L; M. AGLIETTA
MiR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages 2012 Squadrito M.L.; Pucci F.; Magri L.; Moi D.; Gilfillan G.D.; Ranghetti A.; Casazza A.; Mazzone M.; Lyle R.; Naldini L.; De Palma M.
Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells. 2002 AILLES L.; SCHMIDT M.; SANTONI DE SIO F.; GLIMM H.; CAVALLERI S.; BRUNO S.; V. PIACIBELLO; VON KALLE C.; NALDINI L.
Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. 2005 M. DE PALMA; E. MONTINI; F.R. SANTONI DE SIO; F. BENEDICENTI; A. GENTILE; E. MEDICO; L. NALDINI
RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis 2005 TAULLI R; ACCORNERO P; FOLLENZI A; MANGANO T; MOROTTI A; SCUOPPO C; FORNI PE; BERSANI F; CREPALDI T; CHIARLE R; NALDINI L; PONZETTO C
Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors 2002 Vigna, Elisa; Cavalieri, Simona; Ailles, Laurie; Geuna, Massimo; Loew, Rainer; Bujard, Hermann; Naldini, Luigi
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. 1991 Naldini L; Weidner KM; Vigna E; Gaudino G; Bardelli A; Ponzetto C; Narsimhan RP; Hartmann G; Zarnegar R; Michalopoulos GK; Birchmeier W; Comoglio PM
Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models 2011 Casazza A; Fu X; Johansson I; Capparuccia L; Andersson F; Giustacchini A; Squadrito ML; Venneri MA; Mazzone M; Larsson E; Carmeliet P; De Palma M; Naldini L; Tamagnone L; Rolny C.
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor 2004 MICHIELI P; MAZZONE M; BASILICO C; CAVASSA S; SOTTILE A; NALDINI L; P. COMOGLIO
The MET oncogene drives a genetic programme linking cancer to haemostasis 2005 BOCCACCIO C.; SABATINO G; MEDICO E.; GIROLAMI F.; FOLLENZI A.; REATO G.; SOTTILE A.; NALDINI L.; COMOGLIO PM
Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). 1994 LONGATI P; BARDELLI A; PONZETTO C; NALDINI L; COMOGLIO PM